CHU de Nice
Nice, Alpes Maritimes, 06000, France
NCT Number: NCT05370183
Mini-optics has been used in orthopedics for a short time. The Nanoscope used in this study is marketed by Arthrex. Its main indications concern knee, elbow, wrist, carp and small joints of long fingers for diagnostic and sometimes therapeutic purposes. Some teams use it to replace expensive radiological examinations and/or difficult to access, in consultation, for diagnostic in the knee, but also for therapeutic for partial meniscectomy with several related publications. The investigators recently published a feasibility study of isolated tenotomy of the biceps with this minimally invasive device in consultation (first indexed article describing this technique).
This project is part of the broader context of "In Office" surgery, for which there are many applications. Through the miniaturisation of optics and access to "portable" technologies, surgical procedures can now be performed in consultation ("In Office"). For example: release of the carpal tunnel or ulnar canal to the elbow under ultrasound, partial meniscectomy, removal of foreign body from the elbow in consultation.
Indeed, in addition to the technical interest of this innovation for a simple and frequent surgical procedure, it should make it possible to transpose anxiety management for the patient, time-consuming and costly for the institution into a heavy technical platform (operating room) towards a simplified, fast and streamlined approach in consultation. In the scientific literature, other equivalent surgical procedures have already been identified and performed in consultation with various tools (carpal tunnel, ulnar nerve in the elbow, meniscectomy in the knee but also in other surgical specialties such as cataract in ophthalmology) with better patient satisfaction, improved patient journey, reduced costs, an increase in the number of patients treated.
The investigators wish to demonstrate the non-inferiority of intraarticular tenotomy of the biceps long head performed in consultation with mini-optics and local anaesthesia compared to the operating room in order to modify practices and optimize the management of patients within the institution while improving their satisfaction.
This study is active but is not currently recruiting participants.
Notify Me18 year and older
All sexes
Interventional
Not applicable
Nice, Alpes Maritimes, 06000, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Using mini-optics a minimally invasive device, hypermabulatory tenotomy is performed in consultation, with a local anethesia
Operating room tenotomy is performed according standard practice, with general anesthesia.
Time frame: At inclusion (V0)
Pain felt will be assessed with a visual and analog scale for pain. The scale ranges from 0 (no pain) to 10 (maximum thinkable pain). Limit of non-inferiority is fixed to 1.5 on this scale.
Time frame: 3 hours after surgery (V1)
Pain felt will be assessed with a visual and analog scale for pain. The scale ranges from 0 (no pain) to 10 (maximum thinkable pain). Limit of non-inferiority is fixed to 1.5 on this scale.
Time frame: The day after surgery (V2)
Pain felt will be assessed with a visual and analog scale for pain. The scale ranges from 0 (no pain) to 10 (maximum thinkable pain). Limit of non-inferiority is fixed to 1.5 on this scale.
Time frame: 2 weeks after surgery (V3)
Pain felt will be assessed with a visual and analog scale for pain. The scale ranges from 0 (no pain) to 10 (maximum thinkable pain). Limit of non-inferiority is fixed to 1.5 on this scale.
Time frame: 6 weeks after surgery (V4)
Pain felt will be assessed with a visual and analog scale for pain. The scale ranges from 0 (no pain) to 10 (maximum thinkable pain). Limit of non-inferiority is fixed to 1.5 on this scale.
Time frame: 3 months after surgery (V5)
Pain felt will be assessed with a visual and analog scale for pain. The scale ranges from 0 (no pain) to 10 (maximum thinkable pain). Limit of non-inferiority is fixed to 1.5 on this scale.
Time frame: 6 months after surgery (V6)
Pain felt will be assessed with a visual and analog scale for pain. The scale ranges from 0 (no pain) to 10 (maximum thinkable pain). Limit of non-inferiority is fixed to 1.5 on this scale.
Time frame: 12 months after surgery (V7)
Pain felt will be assessed with a visual and analog scale for pain. The scale ranges from 0 (no pain) to 10 (maximum thinkable pain). Limit of non-inferiority is fixed to 1.5 on this scale.
Time frame: 2 weeks (V3) after surgery
Number of scare will be visually evaluated by investigators
Time frame: 6 weeks (V4) after surgery
Number of scare will be visually evaluated by investigators
Time frame: 3 months (V5) after surgery
Number of scare will be visually evaluated by investigators
Time frame: 6 months (V6) after surgery
Number of scare will be visually evaluated by investigators
Time frame: 12 months (V7) after surgery
Number of scare will be visually evaluated by investigators
Time frame: 2 weeks (V3) after surgery
Scare's length will be assessed by investigator with a small ruler, in millimeter.
Time frame: 6 weeks after surgery
Scare's length will be assessed by investigator with a small ruler, in millimeter.
Time frame: 3 months (V5) after surgery
Scare's length will be assessed by investigator with a small ruler, in millimeter.
Time frame: 6 months (V6) after surgery
Scare's length will be assessed by investigator with a small ruler, in millimeter.
Time frame: 12 months (V7) after surgery
Scare's length will be assessed by investigator with a small ruler, in millimeter.
Time frame: 2 weeks (V3) after surgery
Scare's width will be assessed by investigator with a small ruler, in millimeter.
Time frame: 6 weeks (V4) after surgery
Scare's width will be assessed by investigator with a small ruler, in millimeter.
Time frame: 3 months (V5) after surgery
Scare's width will be assessed by investigator with a small ruler, in millimeter.
Time frame: 6 months (V6) after surgery
Scare's width will be assessed by investigator with a small ruler, in millimeter.
Time frame: 12 months (V7) after surgery
Scare's width will be assessed by investigator with a small ruler, in millimeter.
Time frame: 2 weeks (V3) after surgery
Time to onset will be evaluated by investigator, in number of days.
Time frame: 6 weeks (V4) after surgery
Time to onset will be evaluated by investigator, in number of days.
Time frame: 3 months (V5) after surgery
Time to onset will be evaluated by investigator, in number of days.
Time frame: 6 months (V6) after surgery
Time to onset will be evaluated by investigator, in number of days.
Time frame: 12 months (V7) after surgery
Time to onset will be evaluated by investigator, in number of days.
Time frame: 2 weeks (V3) after surgery
Desunion will be evaluated by investigator, with 2 possible values : yes or no.
Time frame: 6 weeks (V4) after surgery
Desunion will be evaluated by investigator, with 2 possible values : yes or no.
Time frame: 3 months (V5) after surgery
Desunion will be evaluated by investigator, with 2 possible values : yes or no.
Time frame: 6 months (V6) after surgery
Desunion will be evaluated by investigator, with 2 possible values : yes or no.
Time frame: 12 months (V7) after surgery
Desunion will be evaluated by investigator, with 2 possible values : yes or no.
Time frame: At inclusion (V0)
Active and passive mobility of both shoulders will be assessed by investigator on following parameters: abduction, adduction, flexion extension, internal and external rotation. All theses paramèters will be assessed with a goniometer, in degree.
Time frame: 2 weeks (V3) after surgery
Active and passive mobility of both shoulders will be assessed by investigator on following parameters: abduction, adduction, flexion extension, internal and external rotation. All theses paramèters will be assessed with a goniometer, in degree.
Time frame: 6 weeks (V4) after surgery
Active and passive mobility of both shoulders will be assessed by investigator on following parameters: abduction, adduction, flexion extension, internal and external rotation. All theses paramèters will be assessed with a goniometer, in degree.
Time frame: 3 months (V5) after surgery
Active and passive mobility of both shoulders will be assessed by investigator on following parameters: abduction, adduction, flexion extension, internal and external rotation. All theses paramèters will be assessed with a goniometer, in degree.
Time frame: 6 months (V6) after surgery
Active and passive mobility of both shoulders will be assessed by investigator on following parameters: abduction, adduction, flexion extension, internal and external rotation. All theses paramèters will be assessed with a goniometer, in degree.
Time frame: 12 months (V7) after surgery
Active and passive mobility of both shoulders will be assessed by investigator on following parameters: abduction, adduction, flexion extension, internal and external rotation. All theses paramèters will be assessed with a goniometer, in degree.
Time frame: At inclusion (V0)
The Subjective Shoulder Value will be evalued by patient himself, by answering the following question: What value do you give to your shoulder, out of 100, compared to a normal shoulder rated at 100% ? this scale ranges from 0 (non-functional shoulder) to 100 (normal shoulder)
Time frame: 2 weeks (V3) after surgery
The Subjective Shoulder Value will be evalued by patient himself, by answering the following question: What value do you give to your shoulder, out of 100, compared to a normal shoulder rated at 100% ? this scale ranges from 0 (non-functional shoulder) to 100 (normal shoulder)
Time frame: 6 weeks (V4) after surgery
The Subjective Shoulder Value will be evalued by patient himself, by answering the following question: What value do you give to your shoulder, out of 100, compared to a normal shoulder rated at 100% ? this scale ranges from 0 (non-functional shoulder) to 100 (normal shoulder)
Time frame: 3 months (V5) after surgery
The Subjective Shoulder Value will be evalued by patient himself, by answering the following question: What value do you give to your shoulder, out of 100, compared to a normal shoulder rated at 100% ? this scale ranges from 0 (non-functional shoulder) to 100 (normal shoulder)
Time frame: 6 months (V6) after surgery
The Subjective Shoulder Value will be evalued by patient himself, by answering the following question: What value do you give to your shoulder, out of 100, compared to a normal shoulder rated at 100% ? this scale ranges from 0 (non-functional shoulder) to 100 (normal shoulder)
Time frame: 12 months (V7) after surgery
The Subjective Shoulder Value will be evalued by patient himself, by answering the following question: What value do you give to your shoulder, out of 100, compared to a normal shoulder rated at 100% ? this scale ranges from 0 (non-functional shoulder) to 100 (normal shoulder)
Time frame: At inclusion (V0)
Patient satisfaction will be evaluated using Constant's score, a quantitative value from 0 to 100.
Time frame: 2 weeks (V3) after surgery
Patient satisfaction will be evaluated using Constant's score, a quantitative value from 0 to 100.
Time frame: 6 weeks (V4) after surgery
Patient satisfaction will be evaluated using Constant's score, a quantitative value from 0 to 100.
Time frame: 3 months (V5) after surgery
Patient satisfaction will be evaluated using Constant's score, a quantitative value from 0 to 100.
Time frame: 6 months (V6) after surgery
Patient satisfaction will be evaluated using Constant's score, a quantitative value from 0 to 100.
Time frame: 12 months (V7) after surgery
Patient satisfaction will be evaluated using Constant's score, a quantitative value from 0 to 100.
Centre Hospitalier Universitaire de Nice
Other
Acronym: NANOBICEPS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07375927
Arthralgia, Joint Diseases
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT06857409
Arthralgia, Joint Diseases
Ankara, Turkey (Türkiye)
View Trial DetailsNCT03653455
Arthralgia, Joint Diseases
Evanston, Illinois, United States
View Trial DetailsNCT06039345
Arthralgia, Joint Diseases
Farmington, Utah, United States
View Trial Details